Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) is a clinically and biologically heterogeneous disease [1] characterized by the amplification of the ERBB2/HER2 gene and/or overexpression of its related kinase receptor protein [2]. Here, ERBB2 is linked to breast cancer.